ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
memorivit capsule 80 mg
vitapharm-com srl, im - ginkgo biloba - capsule - 80 mg
citramon-pharmstandard 240 mg/180 mg/30 mg comprimate
farmstandart-leksredstva sad - acid acetylsalicylicum + paracetamolum + cofeina - comprimate - 240 mg/180 mg/30 mg
danabol comprimate 10 mg
balkan pharmaceuticals srl, sc - metandienonum - comprimate - 10 mg
danabol comprimate 50 mg
balkan pharmaceuticals srl, sc - metandienonum - comprimate - 50 mg
gecoton soluţie perfuzabilă
iuria-farm srl - combinaţie - soluţie perfuzabilă
gecoton soluţie perfuzabilă
iuria-farm srl - combinaţie - soluţie perfuzabilă
ibufen forte suspensie orala 200 mg/5 ml
pharmaceutical works polpharma s.a. - ibuprofenum - suspensie orala - 200 mg/5 ml
ketorolac comprimate filmate 10 mg
upm din borisov sad - ketorolacum - comprimate filmate - 10 mg
laferobion 1000000 ui pulbere pentru soluţie injectabilă
srl uf 'biofarma' - interferonum alfa-2b - pulbere pentru soluţie injectabilă - 1000000 ui